The T1D Talks Pilot Study
Launched by WESTERN MICHIGAN UNIVERSITY SCHOOL OF MEDICINE · Jul 30, 2025
Trial Information
Current as of August 27, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • T1D for at least 1 year
- • the ability to read/write and converse in English
- • reliable internet connection and a virtual meeting capable device (tablet or laptop)
- Exclusion Criteria:
- • a chronic medical condition that requires intensive daily management
- • a significant mental health or cognitive disability that would prevent them from participating
About Western Michigan University School Of Medicine
Western Michigan University School of Medicine is a leading academic institution dedicated to advancing healthcare through innovative research and clinical trials. Committed to enhancing medical education and improving patient outcomes, the School of Medicine conducts a wide range of clinical studies across various specialties. Leveraging a collaborative environment and a diverse patient population, the institution aims to translate scientific discoveries into effective treatments and interventions. With a focus on ethical standards and regulatory compliance, Western Michigan University School of Medicine fosters an atmosphere of integrity and excellence in research, contributing to the advancement of medical knowledge and practice.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Orlando, Florida, United States
Patients applied
Trial Officials
Rachel Wasserman, PhD
Principal Investigator
Western Michigan University Homer Stryker MD School Of Medicine
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported